Chlorophenothane


Curated chemical-disease associations from CTD
Disease IDDisease nameReference
MESH:D000013 Congenital Abnormalities PMID:15095906
MESH:D000022 Abortion, Spontaneous PMID:16120699
MESH:D000071069 Multiple Chronic Conditions PMID:31682807
MESH:D000382 Agricultural Workers' Diseases PMID:12584743; PMID:16487989; PMID:17182642; PMID:17495700; PMID:17932376; PMID:17975796; PMID:19541724; PMID:20061368; PMID:20730623; PMID:24064777
MESH:D001249 Asthma PMID:17932376; PMID:19541724
MESH:D001943 Breast Neoplasms PMID:12709520; PMID:16792888; PMID:17938728
MESH:D002653 Child Behavior Disorders PMID:27466755
MESH:D003072 Cognition Disorders PMID:26630154
MESH:D003110 Colonic Neoplasms PMID:20730623
MESH:D003456 Cryptorchidism PMID:16835070
MESH:D003866 Depressive Disorder PMID:28263910
MESH:D003920 Diabetes Mellitus PMID:31746186
MESH:D004417 Dyspnea PMID:16487989
MESH:D005203 Farmer's Lung PMID:17182642
MESH:D005234 Fatty Liver PMID:31746186
MESH:D005317 Fetal Growth Retardation PMID:22310945
MESH:D005334 Fever PMID:3088650
MESH:D006332 Cardiomegaly PMID:27325568
MESH:D006505 Hepatitis PMID:16487989
MESH:D006528 Carcinoma, Hepatocellular PMID:12597452; PMID:21035526; PMID:6667461
MESH:D006529 Hepatomegaly PMID:11272408; PMID:23684557; PMID:2387028
MESH:D006973 Hypertension PMID:27325568
MESH:D007037 Hypothyroidism PMID:20061368; PMID:24064777
MESH:D007232 Infant, Newborn, Diseases PMID:31682807
MESH:D007248 Infertility, Male PMID:17157474; PMID:17192596; PMID:19303595
MESH:D007333 Insulin Resistance PMID:31746186
MESH:D007674 Kidney Diseases PMID:31682807
MESH:D007859 Learning Disabilities PMID:7589230
MESH:D008103 Liver Cirrhosis PMID:32508177
MESH:D008107 Liver Diseases PMID:15729006
MESH:D008113 Liver Neoplasms PMID:11948501; PMID:15975961; PMID:2431762; PMID:3621148
MESH:D008114 Liver Neoplasms, Experimental PMID:21035526; PMID:6191977; PMID:6499117; PMID:7817132; PMID:838519
MESH:D008228 Lymphoma, Non-Hodgkin PMID:22328999; PMID:25018334; PMID:25337994
MESH:D009207 Myoclonus PMID:1316118; PMID:2986413; PMID:311446; PMID:37558; PMID:520416; PMID:6378651; PMID:7991214
MESH:D009358 Congenital, Hereditary, and Neonatal Diseases and Abnormalities PMID:31682807
MESH:D009369 Neoplasms PMID:23684557; PMID:8820588
MESH:D009765 Obesity PMID:21298090; PMID:31682807; PMID:31746186
MESH:D009845 Oligospermia PMID:19303595
MESH:D010049 Ovarian Diseases PMID:30207508; PMID:31682807
MESH:D011041 Poisoning PMID:18594997; PMID:2436354; PMID:28743278; PMID:4116490
MESH:D011236 Prediabetic State PMID:31746186
MESH:D011297 Prenatal Exposure Delayed Effects PMID:26414943; PMID:28263910; PMID:30822522; PMID:31682807; PMID:31755359
MESH:D011469 Prostatic Diseases PMID:31682807
MESH:D011471 Prostatic Neoplasms PMID:12584743
MESH:D012021 Reflex, Abnormal PMID:3798479
MESH:D012640 Seizures PMID:7991214
MESH:D013733 Testicular Diseases PMID:31682807
MESH:D014202 Tremor PMID:2412143; PMID:2581196; PMID:3088650; PMID:3929313
MESH:D014570 Urologic Diseases PMID:16487989
MESH:D014808 Vitamin D Deficiency PMID:22295072
MESH:D018248 Adenoma, Liver Cell PMID:12597452
MESH:D019954 Neurobehavioral Manifestations PMID:26414943
MESH:D029481 Bronchitis, Chronic PMID:17495700; PMID:17975796
MESH:D050177 Overweight PMID:22027556; PMID:31746186
MESH:D053627 Asthenozoospermia PMID:19303595
MESH:D053713 Azoospermia PMID:31682807
MESH:D056486 Chemical and Drug Induced Liver Injury PMID:11272408; PMID:18675336
MESH:D064420 Drug-Related Side Effects and Adverse Reactions PMID:2370251

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.